IMCR Immunocore Holdings plc
Immunocore Holdings plc (IMCR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 94% planned / 6% discretionary
Largest single sale: $2.8M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Jallal Bahija | CHIEF EXECUTIVE OFFICER | Sell | 11,474 | $32.35 | $371.2K | 12,343 −48.2% of holding | |
| Berman David M | HEAD OF R&D | Sell | 5,965 | $32.35 | $193.0K | 5,859 −50.4% of holding | |
| St Leger Tina Amber | CHIEF HR OFFICER | Sell | 1,000 | $32.35 | $32.4K | 1,119 −47.2% of holding | |
| GOLL JOHN | SVP, FINANCE & CAO | Sell | 698 | $32.35 | $22.6K | 653 −51.7% of holding | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 572 | $40.14 | $23.0K | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 31,341 | $40.26 | $1.3M | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 5,521 | $40.09 | $221.3K | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 69,404 | $40.12 | $2.8M | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 18,020 | $40.03 | $721.3K | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 100 | $40.00 | $4.0K | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 61,849 | $35.23 | $2.2M | None left | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 200 | $35.01 | $7.0K | None left | |
| Berman David M 2 fills | HEAD OF R&D | Sell 10b5-1 | 22,532 | $35.67 | $803.7K | 1,300 −94.5% of holding | |
| Berman David M | HEAD OF R&D | Sell 10b5-1 | 19,081 | $36.28 | $692.3K | None left | |
| Berman David M 2 fills | HEAD OF R&D | Sell 10b5-1 | 31,338 | $36.14 | $1.1M | 1,200 −96.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.